Public health agency the US Food and Drug Administration announced on Friday that it has approved the marketing of the first duodenoscope in the US with a sterile, disposable elevator component that will reduce the number of parts that need to be cleaned and disinfected in between uses under its premarket clearance (510(k)) pathway.
The FDA reportedly granted clearance of the ED34-i10T2 to Pentax of America.
Additionally, the agency stated the Pentax Medical Video ED34-i10T2 model duodenoscope is intended to to be used with endoscopic devices and provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems. The first duodenoscope with disposable elevator piece reduces the number of parts needing disinfection.
In August, the FDA released a safety communication recommending that duodenoscope manufacturers and health care facilities transition to duodenoscopes with disposable components. Disposable designs can simplify or eliminate the need for reprocessing of certain components, which may reduce between-patient duodenoscope contamination.
This FDA clearance is the first duodenoscope device with a disposable elevator component -- a part that has been traditionally difficult to clean and reprocess.
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix
Organon to sell JADA System to Laborie for up to USD465m
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities